Literature DB >> 10963737

Coincident activation of mGluRs and mAChRs imposes theta frequency patterning on synchronised network activity in the hippocampal CA3 region.

S R Cobb1, D O Bulters, C H Davies.   

Abstract

Activation of metabotropic glutamate receptors (mGluRs) with the broad spectrum mGluR agonist 1S,3R ACPD (10-50 microM) induced spontaneous field potentials at low frequencies ('burst-mode' activity; <1 Hz) in the CA3 region of rat hippocampal slices. At higher concentrations (100-400 microM) ACPD switched this form of activity to a second, more complex pattern of activity in which intermittent episodes of theta frequency oscillations predominated ('theta-mode' activity; 4-14 Hz). Both patterns of activity were evoked by selective activation of group I mGluRs and, in particular, could be induced by activation of mGluR5 alone using the subtype selective agonist CHPG (0.5-5 mM). In contrast, activation of group II mGluRs (DCG IV; 100 microM) produced only burst-mode behaviour whilst activation of group III mGluRs (L-AP4; 100 microM) did not result in synchronised network activity. Concurrent extra- and intracellular recordings demonstrated that this mGluR-induced theta-mode activity represented the synchronous firing of CA3 pyramidal cells and that it shared a similar temporal signature to that generated by activation of muscarinic acetylcholine receptors (mAChRs). Furthermore, application of mGluR and mAChR agonists at concentrations sufficient to produce only burst-mode activity when applied individually, produced theta-mode activity when co-applied. These data suggest that the level of activation of different mGluRs and mAChRs crucially determine the pattern of rhythmical network activity generated in the hippocampal CA3 network. These results also indicate that individual receptor subtypes (i.e. mGluR5) can initiate patterns of coherent network activity but that interactions between the cholinergic and glutamatergic transmitter systems may also be important factors in governing the temporal patterning of hippocampal network activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963737     DOI: 10.1016/s0028-3908(00)00036-8

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  A model of atropine-resistant theta oscillations in rat hippocampal area CA1.

Authors:  M J Gillies; R D Traub; F E N LeBeau; C H Davies; T Gloveli; E H Buhl; M A Whittington
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

Review 2.  Cholinergic modulation of hippocampal cells and circuits.

Authors:  Stuart R Cobb; Ceri H Davies
Journal:  J Physiol       Date:  2004-11-04       Impact factor: 5.182

3.  Metabotropic glutamate receptor activity induces a novel oscillatory pattern in neonatal rat hypoglossal motoneurones.

Authors:  Elina Sharifullina; Konstantin Ostroumov; Andrea Nistri
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

4.  G9a/GLP histone lysine dimethyltransferase complex activity in the hippocampus and the entorhinal cortex is required for gene activation and silencing during memory consolidation.

Authors:  Swati Gupta-Agarwal; Aimee V Franklin; Thomas Deramus; Muriah Wheelock; Robin L Davis; Lori L McMahon; Farah D Lubin
Journal:  J Neurosci       Date:  2012-04-18       Impact factor: 6.167

5.  Developmental changes in short-term facilitation are opposite at temporoammonic synapses compared to Schaffer collateral synapses onto CA1 pyramidal cells.

Authors:  Haley E Speed; Lynn E Dobrunz
Journal:  Hippocampus       Date:  2009-02       Impact factor: 3.899

6.  Metabotropic Acetylcholine and Glutamate Receptors Mediate PI(4,5)P2 Depletion and Oscillations in Hippocampal CA1 Pyramidal Neurons in situ.

Authors:  Sandra Hackelberg; Dominik Oliver
Journal:  Sci Rep       Date:  2018-08-28       Impact factor: 4.379

7.  MGluR5 mediates the interaction between late-LTP, network activity, and learning.

Authors:  Arthur Bikbaev; Sergey Neyman; Richard Teke Ngomba; P Jeffrey Conn; Jeffrey Conn; Ferdinando Nicoletti; Denise Manahan-Vaughan
Journal:  PLoS One       Date:  2008-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.